Oppenheimer & CO Inc Bionano Genomics, Inc. Transaction History

Oppenheimer & CO Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$0.57 - $1.16 $51 - $105	91 Added 0.24%	37,546 $22,000
Q1 2023 May 10, 2023	SELL	$1.06 - $1.97 $273 - $508	-258 Reduced 0.68%	37,455 $41,000
Q4 2022 Feb 07, 2023	SELL	$1.4 - $25.4 $1,538 - $27,914	-1,099 Reduced 2.83%	37,713 $55,000
Q3 2022 Nov 14, 2022	BUY	$0.36 - $36.0 $304 - $30,456	846 Added 2.23%	38,812 $71,000
Q2 2022 Aug 08, 2022	SELL	$12.3 - $27.3 $347,056 - $770,296	-28,216 Reduced 42.63%	37,966 $52,000
Q1 2022 May 12, 2022	SELL	$16.6 - $32.3 $497,402 - $967,837	-29,964 Reduced 31.17%	66,182 $171,000
Q4 2021 Feb 02, 2022	SELL	$29.9 - $61.2 $3.33 Million - $6.83 Million	-111,529 Reduced 53.7%	96,146 $287,000
Q3 2021 Nov 12, 2021	BUY	$51.4 - $68.2 $5,911 - $7,843	115 Added 0.06%	207,675 $1.14 Million
Q2 2021 Aug 03, 2021	BUY	$44.1 - $84.0 $7.08 Million - $13.5 Million	160,552 Added 341.54%	207,560 $1.52 Million
Q1 2021 May 10, 2021	BUY	$47.0 - $155.7 $2.21 Million - $7.32 Million	47,008 New	47,008 $380,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $58M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.